Your browser doesn't support javascript.
loading
Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
Yasuda, Kei; Watkins, Amanda A; Kochar, Guneet S; Wilson, Gabriella E; Laskow, Bari; Richez, Christophe; Bonegio, Ramon G; Rifkin, Ian R.
Affiliation
  • Yasuda K; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Watkins AA; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Kochar GS; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Wilson GE; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Laskow B; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Richez C; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Bonegio RG; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Rifkin IR; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
PLoS One ; 9(7): e103478, 2014.
Article in En | MEDLINE | ID: mdl-25076492

Full text: 1 Database: MEDLINE Main subject: GTPase-Activating Proteins / Interferon Regulatory Factors / Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Animals Language: En Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: GTPase-Activating Proteins / Interferon Regulatory Factors / Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Animals Language: En Year: 2014 Type: Article